Argent Advisors’s Orthofix Medical OFIX Stock Holding History

Argent Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4	Closed	–	–	383
2019 Q4	$0	Buy	+4	New	+$188	﹤0.01%	536

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Argent Advisors's OFIX Position: Q1 2020 in Review

Argent Advisors sold out of Orthofix Medical (OFIX) in Q1 2020, closing a stake of 4 shares.

Argent Advisors first reported a position in OFIX in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 145 funds tracked by Wall St. Rank hold OFIX as of Q1 2020.

Argent Advisors reported no remaining Orthofix Medical position as of Q1 2020 after selling out during the quarter.
Argent Advisors sold 4 Orthofix Medical shares in Q1 2020.
Argent Advisors first reported a position in Orthofix Medical in Q4 2019 and held it in 1 quarter.
Argent Advisors's Orthofix Medical position peaked at $0 in Q4 2019.
145 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2020.

Based on Argent Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.